JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kantor, L.
Right arrow Articles by Gnegy, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kantor, L.
Right arrow Articles by Gnegy, M. E.

Vol. 284, Issue 2, 592-598, February 1998

Protein Kinase C Inhibitors Block Amphetamine-Mediated Dopamine Release in Rat Striatal Slices1

L. Kantor and M. E. Gnegy

Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan

The stimulant drug amphetamine is postulated to enhance dopamine release through the plasmalemmal dopamine transporter by an exchange diffusion with synaptosomal dopamine. Because protein kinase C has been shown to have an effect on dopamine transporter activity, we examined the effect of protein kinase C inhibitors on endogenous dopamine release stimulated by amphetamine in perfused rat striatal slices. At concentrations of 1 µM, the selective protein kinase C inhibitors chelerythrine, Ro31-8220 and calphostin C nearly completely inhibited endogenous dopamine release elicited by 1 µM amphetamine. The inactive analog bisindoylmaleimide V had no effect. Extracellular Ca++ was not required for the effect of the inhibitors. The importance of vesicular dopamine release was examined by determining inhibitor activity in reserpine-treated rats. Dopamine release elicited by 1 µM amphetamine was not significantly altered in reserpine-treated rats compared with control animals. Ro31-8220 at 1 µM completely blocked amphetamine-induced dopamine release in reserpine-treated rats. Activation of protein kinase C with 250 nM of the phorbol ester 12-O-tetradecanoylphorbol 13-acetate increased dopamine release, and the release was not additive with 1 µM amphetamine. Both chelerythrine and Ro31-8220 at 1 µM increased [3H]dopamine uptake by 17% and 30%, respectively, whereas a brief exposure to 12-O-tetradecanoylphorbol 13-acetate slightly inhibited [3H]dopamine uptake. Our results suggest that amphetamine-mediated dopamine release through the plasmalemmal transporter is highly dependent on protein kinase C activity.


0022-3565/98/2842-0592$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurosci.Home page
C. A. Furman, R. Chen, B. Guptaroy, M. Zhang, R. W. Holz, and M. Gnegy
Dopamine and Amphetamine Rapidly Increase Dopamine Transporter Trafficking to the Surface: Live-Cell Imaging Using Total Internal Reflection Fluorescence Microscopy
J. Neurosci., March 11, 2009; 29(10): 3328 - 3336.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Chen, C. A. Furman, M. Zhang, M. N. Kim, R. W. Gereau IV, M. Leitges, and M. E. Gnegy
Protein Kinase C{beta} Is a Critical Regulator of Dopamine Transporter Trafficking and Regulates the Behavioral Response to Amphetamine in Mice
J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 912 - 920.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Guptaroy, M. Zhang, E. Bowton, F. Binda, L. Shi, H. Weinstein, A. Galli, J. A. Javitch, R. R. Neubig, and M. E. Gnegy
A Juxtamembrane Mutation in the N Terminus of the Dopamine Transporter Induces Preference for an Inward-Facing Conformation
Mol. Pharmacol., March 1, 2009; 75(3): 514 - 524.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. S. Goodwin, G. A. Larson, J. Swant, N. Sen, J. A. Javitch, N. R. Zahniser, L. J. De Felice, and H. Khoshbouei
Amphetamine and Methamphetamine Differentially Affect Dopamine Transporters in Vitro and in Vivo
J. Biol. Chem., January 30, 2009; 284(5): 2978 - 2989.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Cervinski, J. D. Foster, and R. A. Vaughan
Psychoactive Substrates Stimulate Dopamine Transporter Phosphorylation and Down-regulation by Cocaine-sensitive and Protein Kinase C-dependent Mechanisms
J. Biol. Chem., December 9, 2005; 280(49): 40442 - 40449.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. M. Kahlig, F. Binda, H. Khoshbouei, R. D. Blakely, D. G. McMahon, J. A. Javitch, and A. Galli
Amphetamine induces dopamine efflux through a dopamine transporter channel
PNAS, March 1, 2005; 102(9): 3495 - 3500.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Seidel, E. A. Singer, H. Just, H. Farhan, P. Scholze, O. Kudlacek, M. Holy, K. Koppatz, P. Krivanek, M. Freissmuth, et al.
Amphetamines Take Two to Tango: an Oligomer-Based Counter-Transport Model of Neurotransmitter Transport Explores the Amphetamine Action
Mol. Pharmacol., January 1, 2005; 67(1): 140 - 151.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
J. A. Quiroz, T. D. Gould, and H. K. Manji
MOLECULAR EFFECTS of lithium
Mol. Interv., October 1, 2004; 4(5): 259 - 272.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. A. Vaughan
Phosphorylation and Regulation of Psychostimulant-Sensitive Neurotransmitter Transporters
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Kahlig, J. A. Javitch, and A. Galli
Amphetamine Regulation of Dopamine Transport: COMBINED MEASUREMENTS OF TRANSPORTER CURRENTS AND TRANSPORTER IMAGING SUPPORT THE ENDOCYTOSIS OF AN ACTIVE CARRIER
J. Biol. Chem., March 5, 2004; 279(10): 8966 - 8975.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Khoshbouei, H. Wang, J. D. Lechleiter, J. A. Javitch, and A. Galli
Amphetamine-induced Dopamine Efflux. A VOLTAGE-SENSITIVE AND INTRACELLULAR Na+-DEPENDENT MECHANISM
J. Biol. Chem., March 28, 2003; 278(14): 12070 - 12077.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. Vezina, D. S. Lorrain, G. M. Arnold, J. D. Austin, and N. Suto
Sensitization of Midbrain Dopamine Neuron Reactivity Promotes the Pursuit of Amphetamine
J. Neurosci., June 1, 2002; 22(11): 4654 - 4662.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. P. Hansen, E. L. Riddle, V. Sandoval, J. M. Brown, J. W. Gibb, G. R. Hanson, and A. E. Fleckenstein
Methylenedioxymethamphetamine Decreases Plasmalemmal and Vesicular Dopamine Transport: Mechanisms and Implications for Neurotoxicity
J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 1093 - 1100.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. H. Sitte, B. Hiptmair, J. Zwach, C. Pifl, E. A. Singer, and P. Scholze
Quantitative Analysis of Inward and Outward Transport Rates in Cells Stably Expressing the Cloned Human Serotonin Transporter: Inconsistencies with the Hypothesis of Facilitated Exchange Diffusion
Mol. Pharmacol., April 16, 2001; 59(5): 1129 - 1137.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
M. Batchelor and J. O. Schenk
Protein Kinase A Activity May Kinetically Upregulate the Striatal Transporter for Dopamine
J. Neurosci., December 15, 1998; 18(24): 10304 - 10309.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.